Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Janumet (sitagliptin/metformin) and Onglyza (saxagliptin) are both medications used to treat Type 2 diabetes, but they have some key differences. Janumet is a combination of two drugs: sitagliptin (a DPP-4 inhibitor) and metformin (a biguanide). Onglyza, on the other hand, contains only saxagliptin, which is also a DPP-4 inhibitor. Janumet is available in both extended-release and immediate-release forms, and is taken once or twice daily respectively. Onglyza is only taken once daily. Janumet can cause side effects like diarrhea and upper respiratory infections, whereas Onglyza may lead to urinary tract infections and headaches. Additionally, Janumet is not recommended for people with severe kidney problems. Janumet is only avaolable as a brand name medication, while Onglyza has a generic version available, making it potentially more affordable. Both medications can cause serious side effects like pancreatitis and heart failure, so it's important to discuss your medical history with your healthcare team.
Janumet (sitagliptin / metformin)
Saxagliptin (Onglyza)
Janumet (sitagliptin / metformin)
Saxagliptin (Onglyza)
Summary of Janumet vs. Onglyza
Summary for DPP-4 inhibitor / Biguanide
Prescription only
Janumet (sitagliptin / metformin) is a medication for adults with Type 2 diabetes. It contains two different diabetes medications that work together to help control blood sugar. One is sitagliptin, a DPP-4 inhibitor, and the other is metformin, a biguanide. The Janumet immediate-release tablets are taken by mouth twice a day. It works best when used with a balanced meal plan and exercise routine. Some side effects are diarrhea, upper respiratory tract infection, and headache. There's only a brand-name version of Janumet; there's no generic version yet.
Summary for DPP-4 inhibitor
Prescription only
Saxagliptin (Onglyza) is an add-on medication to exercise and a balanced, nutritious diet to improve blood sugar control in adults with Type 2 diabetes. It belongs to the drug class called dipeptidyl peptidase-4 (DPP-4) inhibitors. The saxagliptin (Onglyza) dosage is taken by mouth once daily. Possible side effects include certain infections and headaches. The brand name, Onglyza, is no longer available. But the lower-cost generic version is still available.